now create a 10 X 10 table and some images on types of cancer
Reading Document
Medical Text Search
types of cancer classification epidemiology symptoms treatment prognosis
Medical Image Search
types of cancer tumor histology pathology imaging
GradeResponse
GradeResponse
Here is a comprehensive 10 × 10 table on types of cancer followed by relevant medical images.
10 × 10 Table: Types of Cancer
| # | Cancer Type | Primary Organ/Site | Cell of Origin | Key Risk Factors | Common Symptoms | Diagnostic Tool | Tumor Marker | 1st-Line Treatment | 5-Year Survival Rate |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Lung Cancer | Lung | Epithelial (bronchial) | Smoking, radon, asbestos | Cough, hemoptysis, dyspnea, weight loss | CT scan, bronchoscopy, biopsy | CEA, CYFRA 21-1 | Surgery, platinum-based chemo, immunotherapy (PD-L1) | ~25% (all stages) |
| 2 | Breast Cancer | Breast | Ductal/lobular epithelium | BRCA1/2 mutation, HRT, age, obesity | Breast lump, nipple discharge, skin dimpling | Mammography, MRI, core biopsy | CA 15-3, CEA | Surgery ± radiation, hormone therapy, HER2-targeted therapy | ~91% (all stages) |
| 3 | Prostate Cancer | Prostate | Acinar glandular cells | Age >65, African ancestry, family history | Urinary frequency, weak stream, nocturia | PSA, TRUS biopsy, MRI | PSA, PAP | Active surveillance, radical prostatectomy, EBRT, ADT | ~98% (localized) |
| 4 | Colorectal Cancer | Colon / Rectum | Colonic epithelium (polyps) | Low-fiber diet, IBD, Lynch syndrome | Rectal bleeding, change in bowel habits, weight loss | Colonoscopy, CT colonography | CEA, CA 19-9 | Surgery, FOLFOX/FOLFIRI chemo, bevacizumab | ~65% (all stages) |
| 5 | Skin (Melanoma) | Skin | Melanocytes | UV exposure, fair skin, family history | Changing mole (ABCDE criteria), ulceration | Dermoscopy, excisional biopsy | LDH, S100B | Wide excision, immunotherapy (anti-PD-1/CTLA-4), targeted therapy (BRAF/MEK inhibitors) | ~93% (localized); ~30% (metastatic) |
| 6 | Leukemia | Blood / Bone marrow | Hematopoietic stem cells | Radiation, benzene, Down syndrome, prior chemo | Fatigue, pallor, bruising, recurrent infections | CBC, bone marrow biopsy, flow cytometry | LDH, β2-microglobulin | Chemotherapy (AML: 7+3; ALL: multi-agent), TKIs (CML), HSCT | ~65% (all types combined) |
| 7 | Cervical Cancer | Cervix | Squamocolumnar junction cells | HPV 16/18, early sexual activity, smoking, immunosuppression | Abnormal vaginal bleeding, pelvic pain, discharge | Pap smear, colposcopy, biopsy | SCC antigen, CA 125 | Surgery (early), chemoradiation (cisplatin + RT), HPV vaccination (prevention) | ~68% (all stages) |
| 8 | Pancreatic Cancer | Pancreas | Ductal epithelium | Smoking, chronic pancreatitis, T2DM, BRCA2 | Jaundice, back pain, weight loss, steatorrhea | CT/MRI, EUS, ERCP | CA 19-9, CEA | Surgical resection (Whipple), FOLFIRINOX or gemcitabine + nab-paclitaxel | ~12% (all stages) |
| 9 | Lymphoma (Non-Hodgkin) | Lymph nodes / Lymphoid tissue | B or T lymphocytes | EBV, HIV, autoimmune disease, immunosuppression | Painless lymphadenopathy, night sweats, fever, weight loss | CT-PET scan, lymph node biopsy | LDH, β2-microglobulin | R-CHOP (B-cell), CHOP (T-cell), radiation, CAR-T therapy | ~74% (all stages) |
| 10 | Ovarian Cancer | Ovary | Epithelial surface (serous/mucinous) | BRCA1/2, nulliparity, endometriosis, family history | Bloating, pelvic pain, early satiety, urinary urgency | Transvaginal ultrasound, CA 125, CT | CA 125, HE4 | Cytoreductive surgery + carboplatin/paclitaxel, PARP inhibitors (BRCA+) | ~49% (all stages) |
Images: Cancer Types in Pathology & Histology
Lung Cancer — Histologic Type Distribution
Lung Cancer Histologic Types — Adenocarcinoma is the most common (~38%), followed by squamous cell carcinoma (~20%), small cell carcinoma (~14%), large cell carcinoma (~3%), and other types (~25%). Adenocarcinoma predominates in women and never-smokers; squamous and small cell carcinomas are strongly linked to smoking. (Source: webpathology.com)
Key Takeaways
- Most lethal: Pancreatic cancer (5-year survival ~12%) and lung cancer (~25%) carry the worst prognoses due to late-stage diagnosis.
- Most survivable: Prostate cancer (~98% localized), breast cancer (~91%), and melanoma (~93% localized) when caught early.
- Biomarkers drive management: PSA (prostate), CA 125 (ovarian), CA 19-9 (pancreatic), CEA (colorectal) guide both diagnosis and treatment response monitoring.
- Immunotherapy revolution: Cancers like melanoma, lung, and lymphoma have seen dramatically improved outcomes with PD-1/PD-L1 and CTLA-4 checkpoint inhibitors.
- HPV vaccination is the most effective primary prevention strategy for cervical cancer, now also reducing oropharyngeal and anal cancer risk.
This is a shared conversation. Sign in to Orris to start your own chat.